Hims & Hers Health, Inc. (FRA:82W)

Hims & Hers Health Statistics

Total Valuation

FRA:82W has a market cap or net worth of EUR 7.35 billion. The enterprise value is 7.77 billion.

Market Cap	7.35B
Enterprise Value	7.77B

Important Dates

The next estimated earnings date is Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	219.27M
Shares Outstanding	n/a
Shares Change (YoY)	+11.34%
Shares Change (QoQ)	-3.16%
Owned by Insiders (%)	9.41%
Owned by Institutions (%)	89.57%
Float	206.15M

Valuation Ratios

The trailing PE ratio is 64.42 and the forward PE ratio is 34.72.

PE Ratio	64.42
Forward PE	34.72
PS Ratio	3.90
PB Ratio	14.83
P/TBV Ratio	67.96
P/FCF Ratio	64.36
P/OCF Ratio	26.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.77, with an EV/FCF ratio of 68.04.

EV / Earnings	68.10
EV / Sales	4.08
EV / EBITDA	50.77
EV / EBIT	71.63
EV / FCF	68.04

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 1.92.

Current Ratio	1.88
Quick Ratio	1.49
Debt / Equity	1.92
Debt / EBITDA	6.29
Debt / FCF	8.35
Interest Coverage	52.51

Financial Efficiency

Return on equity (ROE) is 26.21% and return on invested capital (ROIC) is 7.33%.

Return on Equity (ROE)	26.21%
Return on Assets (ROA)	5.56%
Return on Invested Capital (ROIC)	7.33%
Return on Capital Employed (ROCE)	7.07%
Revenue Per Employee	1.15M
Profits Per Employee	69,657
Employee Count	1,637
Asset Turnover	1.56
Inventory Turnover	7.12

Taxes

Income Tax	-5.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.21%
50-Day Moving Average	41.25
200-Day Moving Average	40.91
Relative Strength Index (RSI)	45.34
Average Volume (20 Days)	2,386

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.38

Income Statement

In the last 12 months, FRA:82W had revenue of EUR 1.88 billion and earned 114.03 million in profits. Earnings per share was 0.46.

Revenue	1.88B
Gross Profit	1.41B
Operating Income	107.42M
Pretax Income	108.98M
Net Income	114.03M
EBITDA	143.62M
EBIT	107.42M
Earnings Per Share (EPS)	0.46

Balance Sheet

The company has 536.73 million in cash and 952.89 million in debt, giving a net cash position of -416.16 million.

Cash & Cash Equivalents	536.73M
Total Debt	952.89M
Net Cash	-416.16M
Net Cash Per Share	n/a
Equity (Book Value)	495.17M
Book Value Per Share	2.18
Working Capital	336.21M

Cash Flow

In the last 12 months, operating cash flow was 277.06 million and capital expenditures -162.94 million, giving a free cash flow of 114.12 million.

Operating Cash Flow	277.06M
Capital Expenditures	-162.94M
Free Cash Flow	114.12M
FCF Per Share	n/a

Margins

Gross margin is 75.01%, with operating and profit margins of 5.70% and 6.05%.

Gross Margin	75.01%
Operating Margin	5.70%
Pretax Margin	5.78%
Profit Margin	6.05%
EBITDA Margin	7.62%
EBIT Margin	5.70%
FCF Margin	6.06%

Dividends & Yields

FRA:82W does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.34%
Shareholder Yield	-11.34%
Earnings Yield	1.55%
FCF Yield	1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:82W has an Altman Z-Score of 4.5 and a Piotroski F-Score of 4.

Altman Z-Score	4.5
Piotroski F-Score	4